Skip to main content
Tirzepatide vs Semaglutide for Weight Loss: How These GLP-1 Medications Compare
Weight Loss March 31, 2026

Tirzepatide vs Semaglutide for Weight Loss: How These GLP-1 Medications Compare

Tirzepatide vs Semaglutide for Weight Loss: How These GLP-1 Medications Compare

If you have been researching medical weight loss in Delaware, Ohio, you have probably seen two medications mentioned more than any others: semaglutide and tirzepatide. Both are part of a broader medication class used in metabolic and weight management care, and both can be effective tools when prescribed as part of a comprehensive plan.

Below is a clear, patient-friendly overview of how these medications compare, how Glow Medical Group decides which (if any) might be appropriate, and what to expect during a program.

First: what is a GLP-1 receptor agonist?

GLP-1 receptor agonists are a medication class that supports appetite control, slows stomach emptying, and helps regulate blood sugar. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on GLP-1 and on a related pathway called GIP, which is one of the main reasons it is often discussed alongside, but separately from, semaglutide.

Both medications are prescribed based on medical eligibility and individual goals.

How semaglutide works

Semaglutide supports weight management primarily by:

  • Reducing appetite and hunger signals
  • Helping you feel full sooner and longer after meals
  • Slowing how quickly the stomach empties

For many patients, that combination makes it easier to follow a structured nutrition plan without constant cravings or food noise.

How tirzepatide works

Tirzepatide acts on two metabolic pathways instead of one. In addition to GLP-1 receptor activity, it also acts on GIP receptors, which can influence appetite and how the body uses energy and stored fat.

Patients sometimes describe tirzepatide as a stronger appetite-control experience, but individual response varies. The right medication for one person is not automatically the right medication for someone else.

Key differences at a glance

  • Mechanism: Semaglutide acts on GLP-1 only. Tirzepatide acts on GLP-1 and GIP.
  • Dosing: Both are typically administered as a once-weekly injection, with a gradual dose escalation schedule.
  • Side effect profile: Both can cause nausea, constipation, fatigue, or reflux, especially during the first weeks or after dose changes.
  • Individual response: Some patients tolerate one better than the other, or respond more strongly to one. That is a normal part of medical care, not a failure.

Branded vs compounded: an important distinction

You may see semaglutide and tirzepatide discussed in two very different formats: as FDA-approved manufactured medications, and as compounded preparations.

These are not the same thing.

  • FDA-approved manufactured medications are commercially produced and reviewed by the FDA for safety, effectiveness, and quality for their approved uses.
  • Compounded preparations are prepared by a compounding pharmacy or outsourcing facility for patient-specific medical needs. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before dispensing.

At Glow Medical Group, whether a compounded preparation is appropriate is evaluated during a consultation based on individual medical need.

How we decide which (if any) is right for a patient

At Glow Medical Group in Delaware, OH, we do not pick a medication based on hype. We look at:

  • Your health history and current medications
  • Weight history, eating patterns, cravings, and lifestyle
  • Tolerance and response to prior weight management efforts
  • Realistic goals and what you can sustain long term

From there, we discuss options that are clinically appropriate. Medication is one part of a comprehensive plan that also includes nutrition guidance, activity, and ongoing follow-up.

What to expect during a program

Whether the plan involves semaglutide, tirzepatide, an oral option, or a non-medication approach, expect:

  • An initial consultation and review of your goals
  • A nutrition framework that supports protein, hydration, and steady energy
  • A simple, repeatable activity routine. Exercise is recommended for every patient unless there is a medical contraindication discussed in consultation.
  • Ongoing follow-up to adjust the plan as your body and goals change

What about long-term results?

Weight loss is a long-term commitment. After reaching a goal, the focus shifts to maintenance: recalibrated macros, possible dose reduction, and in some cases stopping medication altogether when clinically appropriate. The plan is designed for sustainability, not just a short-term drop on the scale.

Book a consultation in Delaware, OH (or via Ohio telehealth)

If you are weighing options for medical weight loss in Delaware, Ohio or the surrounding Columbus area, schedule a consultation with Glow Medical Group. We will review your goals, discuss medical eligibility, and explain what a safe, individualized plan can look like.


Important disclaimer: This article is for educational purposes only and is not medical advice. All medications are prescribed based on medical eligibility and individual goals and should be discussed with a licensed medical provider.

Sarah Jones

Written by

Sarah Jones

Board-Certified Family Nurse Practitioner

Sarah Jones, FNP-BC, is the founder of Glow Medical Group in Delaware, OH. With specialized post-graduate training in Obesity Medicine, Hormone Replacement Therapy, and Aesthetics, she provides personalized, evidence-based care for medical weight loss, hormone optimization, and aesthetic treatments.

Ready to Start Your Journey?

Schedule a consultation with Sarah to discuss your health and wellness goals.

Book a Consultation